Profiling the SARS-CoV-2-specific T-cell response
- PMID: 38909615
- DOI: 10.1016/S1473-3099(24)00377-3
Profiling the SARS-CoV-2-specific T-cell response
Conflict of interest statement
AS is a consultant for AstraZeneca, Calyptus Pharmaceuticals, Darwin Health, EmerVax, EUROIMMUN, F Hoffman-La Roche, Fortress Biotech, Gilead Sciences, Granite Bio, Gritstone Oncology, Guggenheim Securities, Moderna, Pfizer, RiverVest Venture Partners, and Turnstone Biologics. AG is a consultant for Pfizer. La Jolla Institute for Immunology has filed for patent protection for various aspects of T-cell epitope and vaccine design work. All other authors declare no competing interests.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous